References
- Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K. Prevalence, incidence, and type specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV negative women. J Infect Dis. 2001. 184: 682-690. https://doi.org/10.1086/323081
- Bellaminutti S, Seraceni S, De Seta F, Gheit T, Tommasino M, Comar M. HPV and Chlamydia trachomatis co-detection in young asymptomatic women from high incidence area for cervical cancer. J Med Virol. 2014. 86: 1920-1925. https://doi.org/10.1002/jmv.24041
- Camporiondo MP, Farchi F, Ciccozzi M, Denaro A, Gallone D, Maracchioni F, Favalli C, Ciotti M. Detection of HPV and co-infecting pathogens in healthy Italian women by multiplex real-time PCR. Infez Med. 2016. 24: 12-17.
- Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res. 2002. 89: 191-199. https://doi.org/10.1016/S0168-1702(02)00188-0
- Ekiel AM, Friedek DA, Romanik MK, JozwiakJ, Martirosian G. Occurrence of Ureaplasma parvum and Ureaplasma urealyticum in women with cervical dysplasia in Katowice, Poland. J Korean Med Sci. 2009. 24: 1177-1181. https://doi.org/10.3346/jkms.2009.24.6.1177
- Ji YI. Co-infections with human papillomavirus and Mycoplasma/Ureaplasma spp. in women with abnormal cervical cytology. Gynaecol Obstet. 2017. 1: 1-3.
- Kim HS, Kim TJ, Lee IH, Hong SR. Associations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients. J Gynecol Oncol. 2016. 27: e49. https://doi.org/10.3802/jgo.2016.27.e49
- Kim SI, Yoon JH, Park DC, Lee DS, Lee SJ, Choe HS, Kim JH, Park TC, Lee SJ. Co-infection of Ureaplasma urealyticum and human papilloma virus in asymptomatic sexually active individuals. Int J Med Sci. 2018. 15: 915-920. https://doi.org/10.7150/ijms.26523
- Liu J, Liu W, Liu Y, Zhou X, Zhang Z, Sun Z. Prevalence of microorganisms co-infections in human papillomaviruses infected women in Northern China. Arch Gynecol Obstet. 2016. 293: 595-602. https://doi.org/10.1007/s00404-015-3826-7
- Ljubin-Sternak S, Mestrovic T. Chlamydia trachomatis and genital Mycoplasmas: pathogens with an impact on human reproductive health. J Pathog. 2014. 183167. https://doi.org/10.1155/2014/183167
- Magana-Contreras M, Contreras-Paredes A, Chavez-Blanco A, Lizzano M, De la Cruz-Hernandez Y, De la Cruz-Hernandez E. Prevalence of sexually transmitted pathogens associated with HPV infection in cervical samples in a Mexican population. J Med Virol. 2015. 87: 2098-2105. https://doi.org/10.1002/jmv.24278
- Markowska J, Fischer N, Filas V, Fischer Z, Breborowicz J, Markowski M. The role of Chlamydia trachomatis infection in cervical cancer development. Eur J Gynaecol Oncol. 1999. 20: 144-146.
- Markowska J, Fischer N, Fischer Z, Warchol JB. Chlamydia trachomatis infection in women with CIN and invasive uterine cervix cancer. Significance of hormonal status. Eur J Gynaecol Oncol. 2002. 23: 511-513.
- Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection. The Lancet. 2002. 359: 1085-1092. https://doi.org/10.1016/S0140-6736(02)08150-3
- Paavonen J. Chlamydia trachomatis infections of the female genital tract: state of the art. Ann Med. 2012. 44: 18-28. https://doi.org/10.3109/07853890.2010.546365
- Paba P, Bonifacio D, Di Bonito L, Ombres D, Favalli C, Syrjanen K, Ciotti M. Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology. 2008. 51: 230-234. https://doi.org/10.1159/000156481
- Parthenis C, Panagopoulos P, Margari N, Kottaridi C, Spathis A, Pouliakis A, Konstantoudakis S, Chrelias G, Chrelias C, Papantoniou N, Panayiotides IG, Tsiodras S. The association between sexually transmitted infections, human papillomavirus, and cervical cytology abnormalities among women in Greece. International Journal of Disease. 2018. 73: 72-77.
- Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjose S, Munoz N; IARC Multi-centre Cervical Cancer Study Group. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study. Cancer Causes Control. 2003. 14: 805-814. https://doi.org/10.1023/B:CACO.0000003811.98261.3e
- Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol. 2005. 162: 668-675. https://doi.org/10.1093/aje/kwi262
- Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990. 63: 1129-1136. https://doi.org/10.1016/0092-8674(90)90409-8
- Schmauz R, Okong P, de Villiers EM, Dennin R, Brade L, Lwanga SK, Owor R. Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer. 2989. 43: 805-809. https://doi.org/10.1002/ijc.2910430511
- Silins I, Ryd W, Stre A, Wadell G, Tornberg S, Hansson BG. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer. 2005. 16: 110-115.
- Van Der Pol B. Sexually transmitted infections in women. Scand J Clin Lab Invest Suppl. 2014. 244: 68-74. https://doi.org/10.3109/00365513.2014.936691
- Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990. 248: 76-79. https://doi.org/10.1126/science.2157286
- Zhang D, Li T, Chen L, Zhang X, Zhao G, Liu Z. Epidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing. China. PloS One. 2017. 12: e0178033. https://doi.org/10.1371/journal.pone.0178033
- zur Hausen. H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002. 2: 342-350. https://doi.org/10.1038/nrc798
- zur Hausen H. Papillomaviruses in the causation of human cancers a brief historical account. Virology. 2009. 384: 260-265. https://doi.org/10.1016/j.virol.2008.11.046